|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 262.25 EUR | 0.00% |
|
0.00% | - |
| 06-25 | US prices for new drugs fell in 2025 as fewer costly gene therapies were launched | RE |
| 06-22 | UBS Trims UCB's PT, Affirms Buy Rating | MT |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- UCB Stock
- 0NZT Stock
- Charts UCB
Select your edition
All financial news and data tailored to specific country editions
